RICHARD J. BERMAN - 31 May 2023 Form 4 Insider Report for Context Therapeutics Inc. (CNTX)

Role
Director
Signature
/s/ Alex Levit, Attorney-in-Fact
Issuer symbol
CNTX
Transactions as of
31 May 2023
Net transactions value
$0
Form type
4
Filing time
31 May 2023, 16:52:56 UTC
Previous filing
15 Jun 2023
Next filing
24 Aug 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNTX Stock Option (right to buy) Award $0 +50,000 $0.000000 50,000 31 May 2023 Common Stock 50,000 $0.8700 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable on the earlier of (i) May 31, 2024 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2024 annual meeting of stockholders, subject to continued service with the Issuer.